Solid Biosciences to Present at the Cell & Gene Meeting on the Mesa

October 1 2018

Solid Biosciences to Present at the Cell & Gene Meeting on the Mesa

CAMBRIDGE, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB) today announced that management will present at the Cell & Gene Meeting on the Mesa on Wednesday, October 3, 2018 at 3:30 pm PT in La Jolla, California.

The Cell & Gene Meeting on the Mesa is organized by the Alliance of Regenerative Medicine and the Stanford Stem Cell Clinical Center at UC San Diego. A live video webcast will be available at http://www.meetingonthemesa.com/webcast and will also be published on the conference website shortly after the event.

About Solid Biosciences
Solid Biosciences is a life science company focused solely on finding meaningful therapies for Duchenne muscular dystrophy (DMD). Founded by those touched by the disease, Solid is a center of excellence for DMD, bringing together experts in science, technology and care to drive forward a portfolio of candidates that have life-changing potential. Currently, Solid is progressing programs across four scientific platforms: Corrective Therapies, Disease-Modifying Therapies, Disease Understanding and Assistive Devices. For more information, please visit www.solidbio.com.

Media Contact:
Solid Biosciences
Kate Niazi-Sai
617-337-4680
media@solidbio.com

Investor Contact:
Kendall Investor Relations
Carlo Tanzi, Ph.D.
617-337-4680
investors@solidbio.com

SolidBioLogoDigitalRGB.png

Source: Solid Biosciences Inc.